Report Detail

Pharma & Healthcare Global In-Vitro Diagnostics Market Growth 2019-2024

  • RnM3051023
  • |
  • 05 March, 2019
  • |
  • Global
  • |
  • 178 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
According to Japan’s pharmaceutical Affairs law, In-Vitro Diagnostics is defined as “medical product not administered directly to humans or animals of medicinal products used solely to diagnose disease.” Therefore, In-Vitro Diagnostics are legally classified as medicinal product and strict rules must be observed when developing, manufacturing and controlling the same. Therefore the threshold of obtaining the certification is keep new competitors from entering the market.
In-Vitro Diagnostics is a good investment choice. However, disadvantage factors and threat such as serious competition should be considered.

According to this study, over the next five years the In-Vitro Diagnostics market will register a 4.5% CAGR in terms of revenue, the global market size will reach US$ 70000 million by 2024, from US$ 53900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in In-Vitro Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of In-Vitro Diagnostics market by product type, application, key manufacturers and key regions and countries.

This study considers the In-Vitro Diagnostics value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tissue diagnostics
Professional diagnostic
Molecular diagnostic
Diabetes Monitoring
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Siemens Healthcare
Johnson and Johnson
Becton Dickinson
Abbott Laboratories
Roche Diagnostics
Beckman Coulter Inc
Thermo Scientific
Cobas
Caprion
Merck Millipore
Aptiv Solution
Danaher Corporation
Biomerieux
Bio-Rad Laboratories
Ortho Clinical Diagnostics
Sysmex Corporation
Mindray
Shanghai Kehua Bio-engineering
BioSino Bio-technology
Beijing Leadman Biochemistry
DAAN Gene

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global In-Vitro Diagnostics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of In-Vitro Diagnostics market by identifying its various subsegments.
Focuses on the key global In-Vitro Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the In-Vitro Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of In-Vitro Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global In-Vitro Diagnostics Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global In-Vitro Diagnostics Consumption 2014-2024
        • 2.1.2 In-Vitro Diagnostics Consumption CAGR by Region
      • 2.2 In-Vitro Diagnostics Segment by Type
        • 2.2.1 Tissue diagnostics
        • 2.2.2 Professional diagnostic
        • 2.2.3 Molecular diagnostic
        • 2.2.4 Diabetes Monitoring
      • 2.3 In-Vitro Diagnostics Consumption by Type
        • 2.3.1 Global In-Vitro Diagnostics Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global In-Vitro Diagnostics Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global In-Vitro Diagnostics Sale Price by Type (2014-2019)
      • 2.4 In-Vitro Diagnostics Segment by Application
        • 2.4.1 Diabetes
        • 2.4.2 Infectious Diseases
        • 2.4.3 Oncology
        • 2.4.4 Cardiology
        • 2.4.5 HIV
        • 2.4.6 Other
      • 2.5 In-Vitro Diagnostics Consumption by Application
        • 2.5.1 Global In-Vitro Diagnostics Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global In-Vitro Diagnostics Value and Market Share by Application (2014-2019)
        • 2.5.3 Global In-Vitro Diagnostics Sale Price by Application (2014-2019)

      3 Global In-Vitro Diagnostics by Players

      • 3.1 Global In-Vitro Diagnostics Sales Market Share by Players
        • 3.1.1 Global In-Vitro Diagnostics Sales by Players (2017-2019)
        • 3.1.2 Global In-Vitro Diagnostics Sales Market Share by Players (2017-2019)
      • 3.2 Global In-Vitro Diagnostics Revenue Market Share by Players
        • 3.2.1 Global In-Vitro Diagnostics Revenue by Players (2017-2019)
        • 3.2.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2017-2019)
      • 3.3 Global In-Vitro Diagnostics Sale Price by Players
      • 3.4 Global In-Vitro Diagnostics Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global In-Vitro Diagnostics Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players In-Vitro Diagnostics Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 In-Vitro Diagnostics by Regions

      • 4.1 In-Vitro Diagnostics by Regions
        • 4.1.1 Global In-Vitro Diagnostics Consumption by Regions
        • 4.1.2 Global In-Vitro Diagnostics Value by Regions
      • 4.2 Americas In-Vitro Diagnostics Consumption Growth
      • 4.3 APAC In-Vitro Diagnostics Consumption Growth
      • 4.4 Europe In-Vitro Diagnostics Consumption Growth
      • 4.5 Middle East & Africa In-Vitro Diagnostics Consumption Growth

      5 Americas

      • 5.1 Americas In-Vitro Diagnostics Consumption by Countries
        • 5.1.1 Americas In-Vitro Diagnostics Consumption by Countries (2014-2019)
        • 5.1.2 Americas In-Vitro Diagnostics Value by Countries (2014-2019)
      • 5.2 Americas In-Vitro Diagnostics Consumption by Type
      • 5.3 Americas In-Vitro Diagnostics Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC In-Vitro Diagnostics Consumption by Countries
        • 6.1.1 APAC In-Vitro Diagnostics Consumption by Countries (2014-2019)
        • 6.1.2 APAC In-Vitro Diagnostics Value by Countries (2014-2019)
      • 6.2 APAC In-Vitro Diagnostics Consumption by Type
      • 6.3 APAC In-Vitro Diagnostics Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe In-Vitro Diagnostics by Countries
        • 7.1.1 Europe In-Vitro Diagnostics Consumption by Countries (2014-2019)
        • 7.1.2 Europe In-Vitro Diagnostics Value by Countries (2014-2019)
      • 7.2 Europe In-Vitro Diagnostics Consumption by Type
      • 7.3 Europe In-Vitro Diagnostics Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa In-Vitro Diagnostics by Countries
        • 8.1.1 Middle East & Africa In-Vitro Diagnostics Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa In-Vitro Diagnostics Value by Countries (2014-2019)
      • 8.2 Middle East & Africa In-Vitro Diagnostics Consumption by Type
      • 8.3 Middle East & Africa In-Vitro Diagnostics Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 In-Vitro Diagnostics Distributors
      • 10.3 In-Vitro Diagnostics Customer

      11 Global In-Vitro Diagnostics Market Forecast

      • 11.1 Global In-Vitro Diagnostics Consumption Forecast (2019-2024)
      • 11.2 Global In-Vitro Diagnostics Forecast by Regions
        • 11.2.1 Global In-Vitro Diagnostics Forecast by Regions (2019-2024)
        • 11.2.2 Global In-Vitro Diagnostics Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global In-Vitro Diagnostics Forecast by Type
      • 11.8 Global In-Vitro Diagnostics Forecast by Application

      12 Key Players Analysis

      • 12.1 Siemens Healthcare
        • 12.1.1 Company Details
        • 12.1.2 In-Vitro Diagnostics Product Offered
        • 12.1.3 Siemens Healthcare In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Siemens Healthcare News
      • 12.2 Johnson and Johnson
        • 12.2.1 Company Details
        • 12.2.2 In-Vitro Diagnostics Product Offered
        • 12.2.3 Johnson and Johnson In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Johnson and Johnson News
      • 12.3 Becton Dickinson
        • 12.3.1 Company Details
        • 12.3.2 In-Vitro Diagnostics Product Offered
        • 12.3.3 Becton Dickinson In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Becton Dickinson News
      • 12.4 Abbott Laboratories
        • 12.4.1 Company Details
        • 12.4.2 In-Vitro Diagnostics Product Offered
        • 12.4.3 Abbott Laboratories In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Abbott Laboratories News
      • 12.5 Roche Diagnostics
        • 12.5.1 Company Details
        • 12.5.2 In-Vitro Diagnostics Product Offered
        • 12.5.3 Roche Diagnostics In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Roche Diagnostics News
      • 12.6 Beckman Coulter Inc
        • 12.6.1 Company Details
        • 12.6.2 In-Vitro Diagnostics Product Offered
        • 12.6.3 Beckman Coulter Inc In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Beckman Coulter Inc News
      • 12.7 Thermo Scientific
        • 12.7.1 Company Details
        • 12.7.2 In-Vitro Diagnostics Product Offered
        • 12.7.3 Thermo Scientific In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Thermo Scientific News
      • 12.8 Cobas
        • 12.8.1 Company Details
        • 12.8.2 In-Vitro Diagnostics Product Offered
        • 12.8.3 Cobas In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Cobas News
      • 12.9 Caprion
        • 12.9.1 Company Details
        • 12.9.2 In-Vitro Diagnostics Product Offered
        • 12.9.3 Caprion In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Caprion News
      • 12.10 Merck Millipore
        • 12.10.1 Company Details
        • 12.10.2 In-Vitro Diagnostics Product Offered
        • 12.10.3 Merck Millipore In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Merck Millipore News
      • 12.11 Aptiv Solution
      • 12.12 Danaher Corporation
      • 12.13 Biomerieux
      • 12.14 Bio-Rad Laboratories
      • 12.15 Ortho Clinical Diagnostics
      • 12.16 Sysmex Corporation
      • 12.17 Mindray
      • 12.18 Shanghai Kehua Bio-engineering
      • 12.19 BioSino Bio-technology
      • 12.20 Beijing Leadman Biochemistry
      • 12.21 DAAN Gene

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on In-Vitro Diagnostics . Industry analysis & Market Report on In-Vitro Diagnostics is a syndicated market report, published as Global In-Vitro Diagnostics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of In-Vitro Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,928.00
      4,392.00
      5,856.00
      3,418.44
      5,127.66
      6,836.88
      578,060.40
      867,090.60
      1,156,120.80
      305,353.80
      458,030.70
      610,707.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report